Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT

Abdallah Mohamed; Houda Bahig; Michalis Aristophanous; Pierre Blanchard; Mona Kamal; Yao Ding; Carlos Cárdenas; Kristy K. Brock; Stephen Y. Lai; Katherine A. Hutcheson; Jack Phan; Jihong Wang; Geoffrey Ibbott; Refaat E. Gabr; Ponnada A. Narayana; Adam S. Garden; David I. Rosenthal; G. Brandon Gunn; Clifton D. Fuller

doi:10.1016/j.ctro.2018.04.005

Abstract

These in silico results showed that the proposed MRI-guided adaptive approach is technically feasible and advantageous in reducing dose to OARs, especially swallowing musculature.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mohamed et al. (2018) studied this question.

synapsesocial.com/papers/69d974fea1d151c65f6841f7 https://doi.org/10.1016/j.ctro.2018.04.005

View Full Paper

Ask AI

Bookmark

Share

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT

Abstract

Discussion

Cite This Study

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT

Abstract

Discussion

Cite This Study

Keep reading

Keep reading